Commonwealth Equity Services’s PDL BioPharma, Inc. PDLI Stock Holding History

Commonwealth Equity Services’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,301	Closed	-$22K	–	2521
2016 Q4	$22K	Sell	10,301 -3,409	-25%	-$9.51K	﹤0.01%	2288
2016 Q3	$46K	Sell	13,710 -51,840	-79%	-$165K	﹤0.01%	2172
2016 Q2	$206K	Sell	65,550 -6,656	-9%	-$22.2K	﹤0.01%	1938
2016 Q1	$240K	Buy	72,206 +1,623	+2%	+$5.06K	﹤0.01%	1791
2015 Q4	$250K	Sell	70,583 -9,746	-12%	-$40.8K	﹤0.01%	1738
2015 Q3	$404K	Buy	80,329 +7,863	+11%	+$45.1K	﹤0.01%	1366
2015 Q2	$466K	Buy	72,466 +10,562	+17%	+$70.7K	﹤0.01%	1372
2015 Q1	$435K	Buy	61,904 +8,269	+15%	+$59.9K	﹤0.01%	1403
2014 Q4	$414K	Sell	53,635 -3,170	-6%	-$25.1K	﹤0.01%	1379
2014 Q3	$424K	Sell	56,805 -13,399	-19%	-$124K	0.01%	1352
2014 Q2	$680K	Buy	70,204 +7,756	+12%	+$69.1K	0.01%	1075
2014 Q1	$519K	Buy	62,448 +20,843	+50%	+$179K	0.01%	1139
2013 Q4	$351K	Buy	41,605 +24,741	+147%	+$208K	0.01%	1344
2013 Q3	$134K	Buy	16,864 +634	+4%	+$5.1K	﹤0.01%	1723
2013 Q2	$125K	Buy	+16,230	New	+$127K	﹤0.01%	1664

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Commonwealth Equity Services's PDLI Position: Q1 2017 in Review

Commonwealth Equity Services sold out of PDL BioPharma, Inc. (PDLI) in Q1 2017, closing a stake of 10,301 shares — an estimated $22K sold.

Commonwealth Equity Services first reported a position in PDLI in Q2 2013 and held it in 15 quarters. The position peaked at $680K in Q2 2014. 174 funds tracked by Wall St. Rank hold PDLI as of Q1 2017.

Commonwealth Equity Services reported no remaining PDL BioPharma, Inc. position as of Q1 2017 after selling out during the quarter.
Commonwealth Equity Services sold 10,301 PDL BioPharma, Inc. shares in Q1 2017, an estimated $22K.
Commonwealth Equity Services first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 15 quarters.
Commonwealth Equity Services's PDL BioPharma, Inc. position peaked at $680K in Q2 2014.
174 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2017.

Based on Commonwealth Equity Services's 13F filing for Q1 2017, filed 15 May 2017.